These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 23649554)
1. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860 [TBL] [Abstract][Full Text] [Related]
3. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257 [TBL] [Abstract][Full Text] [Related]
4. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L; J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid Hormone Replacement Therapy in Hypoparathyroidism: A Meta-Analysis. Liu XX; Zhu XY; Mei GH Horm Metab Res; 2016 Jun; 48(6):377-83. PubMed ID: 27254756 [TBL] [Abstract][Full Text] [Related]
6. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Marcucci G; Della Pepa G; Brandi ML Expert Opin Drug Saf; 2017 May; 16(5):617-625. PubMed ID: 28332412 [TBL] [Abstract][Full Text] [Related]
7. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety. Rubin MR; Cusano NE; Fan WW; Delgado Y; Zhang C; Costa AG; Cremers S; Dworakowski E; Bilezikian JP J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931 [TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human parathyroid hormone (1-84) replacement therapy in a child with hypoparathyroidism. Laurer E; Grünberger J; Naidoo U; Lanzersdorfer R; Wimleitner M; Tischlinger K; Högler W Bone; 2021 Mar; 144():115834. PubMed ID: 33359892 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Mannstadt M; Clarke BL; Vokes T; Brandi ML; Ranganath L; Fraser WD; Lakatos P; Bajnok L; Garceau R; Mosekilde L; Lagast H; Shoback D; Bilezikian JP Lancet Diabetes Endocrinol; 2013 Dec; 1(4):275-83. PubMed ID: 24622413 [TBL] [Abstract][Full Text] [Related]
11. Effects on calcium homeostasis of changing PTH replacement therapy of postoperative hypoparathyroidism from intact PTH to teriparatide: a case series. Bislev LS; Sikjaer T; Rejnmark L Calcif Tissue Int; 2014 Oct; 95(4):374-81. PubMed ID: 25086672 [TBL] [Abstract][Full Text] [Related]
12. AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM. Lakatos P; Bajnok L; Lagast H; Valkusz Z Endocr Pract; 2016 May; 22(5):523-32. PubMed ID: 26684150 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of vitamin D unresponsive hypoparathyroidism with multipulse subcutaneous infusion of teriparatide. Puig-Domingo M; Díaz G; Nicolau J; Fernández C; Rueda S; Halperin I Eur J Endocrinol; 2008 Nov; 159(5):653-7. PubMed ID: 18703565 [TBL] [Abstract][Full Text] [Related]
14. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life. Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F; J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949 [TBL] [Abstract][Full Text] [Related]
15. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy. Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447 [TBL] [Abstract][Full Text] [Related]
16. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. Vokes TJ; Mannstadt M; Levine MA; Clarke BL; Lakatos P; Chen K; Piccolo R; Krasner A; Shoback DM; Bilezikian JP J Clin Endocrinol Metab; 2018 Feb; 103(2):722-731. PubMed ID: 29099947 [TBL] [Abstract][Full Text] [Related]
17. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety. Tay YD; Tabacco G; Cusano NE; Williams J; Omeragic B; Majeed R; Gomez Almonte M; Bilezikian JP; Rubin MR J Clin Endocrinol Metab; 2019 Nov; 104(11):5601-5610. PubMed ID: 31310310 [TBL] [Abstract][Full Text] [Related]